In pregnancy, the decidua is infiltrated by leukocytes promoting fetal development without causing immunological rejection. Murine regulatory T (Treg) cells are known to be important immune regulators at this site. The aim of the study was to characterize the phenotype and origin of Treg cells and determine the quantitative relationship between Treg, T-helper type 1 (T H 1), T H 2, and T H 17 cells in first-trimester human decidua. Blood and decidual CD4 + T cells from 18 healthy firsttrimester pregnant women were analyzed for expression of Tregcell markers (CD25, FOXP3, CD127, CTLA4, and human leukocyte antigen-DR [HLA-DR]), chemokine receptors (CCR4, CCR6, and CXCR3), and the proliferation antigen MKI67 by sixcolor flow cytometry. Treg cells were significantly enriched in decidua and displayed a more homogenous suppressive phenotype with more frequent expression of FOXP3, HLA-DR, and CTLA4 than in blood. More decidual Treg cells expressed MKI67, possibly explaining their enrichment at the fetal-maternal interface. Using chemokine receptor expression profiles of CCR4, CCR6, and CXCR3 as markers for T H 1, T H 2, and T H 17 cells, we showed that T H 17 cells were nearly absent in decidua, whereas T H 2-cell frequencies were similar in blood and decidua. CCR6 + T H 1 cells, reported to secrete high levels of interferon gamma (IFNG), were fewer, whereas the moderately IFNGsecreting CCR6
INTRODUCTION
During pregnancy, the semiallogenic fetus is actively tolerated by the maternal immune system. The human pregnant uterine mucosa, the decidua, is an active immunological tissue, containing a large population of maternal immune cells dynamically changing in composition from ovulation throughout the course of pregnancy [1, 2] . In the first-trimester decidua, the maternal immune cell population is dominated by noncytotoxic, immune-modulating, and trophoblast-regulating uterine CD16 À
CD56
bright natural killer cells [1, 3] . An abundant number of maternal macrophages with an alternative phenotype, associated with immune regulation and tissue remodeling, are also present [4] . T cells are less frequent but have been proposed to play a major role in immune regulation at the fetal-maternal interface [2] . It has long been an accepted view that T-cell activity at the fetal-maternal interface is skewed toward T-helper type 2-like (T H 2-like) immunity [5, 6] , thus contributing to a pregnancy-protecting environment that seems to be disturbed in recurrent abortions [7] . However, several T-cell subsets besides T H 2 have been ascribed regulatory functions, including T H 3 cells, regulatory type 1 cells (T r 1) [8] , and a recently discovered population of human regulatory T (Treg) cells, the forkhead Box P3 (FOXP3)-expressing CD4
þ CD25 high Treg cells [9, 10] . These immunesuppressive cells can be found naturally in both thymus and in the periphery (nTreg cells) [11] or be induced from non-Treg cells (iTreg cells) [10] . The plasticity of Treg cells was recently substantiated when it was shown that Treg cells can develop into interleukin 17 (IL17)-producing cells [12] , indicative of proinflammatory T H 17 cell differentiation [13] . Interestingly, in mice, Treg cells have been suggested to be in a reciprocal relationship with T H 17 cells [14] .
In murine pregnancy, Treg cells play a crucial role for implantation and maintenance, as shown in models of normal [15] and complicated [16] pregnancy. In normal human pregnancy, CD4 þ CD25 þ/high cells have been shown to increase in the circulation [17] [18] [19] . However, this has been disputed by us [20] and by others [21, 22] , the latter group reporting that Treg cells are enhanced in the decidua but not in blood. Reduced occurrence of these cells in both decidua and blood has been associated with preeclampsia [23] and spontaneous abortion [18] . Importantly, the CD4 þ CD25 þ/high population is heterogeneous, consisting of both activated and suppressive cells. Using flow cytometry, we have shown that gating CD25 high cells as CD4 dim results in a lowered contamination of activated FOXP3-negative CD25 high cells within the Treg cell gate [20] . To our knowledge, there are two reports on the occurrence of FOXP3
þ Treg cells at the fetal-maternal interface in second-trimester pregnancy [22, 23] . Further, several other Treg-cell-associated molecules in first-trimester pregnancy deserve to be explored, including cytotoxic T-lymphocyteassociated protein 4 (CTLA4) [24] , human leukocyte antigen-DR (HLA-DR) [25] , and CD127 low [26, 27] , as well as FOXP3
þ Treg cell frequency. Moreover, the origin of decidual Treg cells is unknown, as is their relationship to the recently discovered T H 17 cells, which can be defined by expression of transcription factor rar-related orphan receptor C (RORC) [28] and chemokine receptors CCR4, CCR6, and CXCR3 [29] .
The aim of the study was to assess, using a stringently defined flow cytometric gating strategy [20] , the frequency, phenotype, and origin of first-trimester decidual FOXP3-expressing CD4 dim CD25 high Treg cells compared with blood. Furthermore, we wanted to elucidate the balance between Thelper cell populations in decidua by determining the quantitative relationship between Treg, T H 1, T H 2, and T H 17 cells.
MATERIALS AND METHODS

Subjects
Eighteen healthy pregnant women (median age, 26 yr; range, 17-40 yr) in median Gestational Week 10 (range, Weeks 7-11) undergoing elective surgical abortion at Linköping University Hospital were included in the study. All pregnancies were detected viable and dated by crown-rump-length measurement using ultrasound. Misoprostol (Cytotec; Searle) was given to all patients. The median number of pregnancies, including the current pregnancy, was two (range, one to seven), and the median parity was zero (range, zero to three). Venous blood and decidual tissue were obtained from all pregnant women, and venous blood was collected immediately prior to termination of pregnancy. In addition, venous blood from four healthy, nonpregnant and nulliparous female blood donors (median age, 27 yr; range, 26-29 yr) was used for methodological validation experiments. Informed consent was obtained from all participants. The study was approved by the local ethics committee at Linköping University.
Separation of Tissues and Cells
Vacuum-aspirated abortion tissue was rinsed in sterile saline solution, and decidual tissue, representing the maternal side of the fetal-maternal interface, was macroscopically separated from fetal tissue and placenta. The latter tissues were further handled according to the regulations at the Women's Hospital, Linköping University Hospital. The decidual tissue was placed in Iscove Modified Dulbecco Medium (Gibco BRL/Invitrogen, Paisley, Scotland) supplemented with L-glutamine (292 mg/ml; Sigma Aldrich, Tokyo, Japan), sodium bicarbonate (3.024 g/L; Merck KGaA, Darmstadt, Germany), penicillin (50 IU/ml), streptomycin (50 lg/ml; Cambrex-Lonza, Verviers, Belgium), and 1003 nonessential amino acids (10 ml/L; Gibco BRL). Using a scalpel, the tissue was divided into smaller pieces and minced in a strainer (approximately 0.5-mm pores) to disperse the cells from connective tissue. Such nonenzymatic leukocyte separation has been shown not to affect the expression of critical markers such as CD4 [30, 31] . The cell mixture was placed on Ficoll-Paque plus (GE Healthcare, Uppsala, Sweden), and decidual mononuclear cells (DMNCs) were acquired from the interface, washed by centrifugation at 400 3 g, and filtered through a 30-lm nylon mesh filter (Miltenyi Biotech GmbH, Bergisch Gladbach, Germany). For separation of peripheral blood mononuclear cells (PBMCs), blood was obtained in sodium-heparin-coated (18 IU/ml) tubes (Greiner Bio-One, Kremsmünster, Austria), diluted in Hanks balanced salt solution (Gibco BRL) and placed on Lymphoprep (Axis-Shield, Oslo, Norway). Gradient centrifugation was always initiated within 2 h of sampling.
Flow Cytometry
Equal numbers of matched PBMCs and DMNCs (700 000 to 1 million cells per tube) were labeled for 30 min at 48C with antibodies against human CD45PE-Cy7 (clone HI30), CD45FITC (clone 2D1), CD3APC-Cy7 (clone SK7), CD3Pacific blue (clone UCTH1), CD4APC-Cy7 (clone RPA-4), CD4PerCP (clone SK3), CD25APC (clone 2A3), CD127PE (clone hIL-7R-M21), CD45R0FITC (clone UCHL1), HLA-DR (clone L243), CCR4PE/PECy7 (clone 1G1), CXCR3APC/PE-Cy5 (clone 1C6/CXCR3), CCR6PE/ Alexa647 (clone 11A9), or isotypes (clone X40), all from BD Biosciences (San Jose/San Diego, CA). After washing, cells were permeabilized according to the manufacturers' instructions using the FOXP3 staining kit (eBioscience, San Diego, CA) followed by staining with anti-human Cytotoxic T LymphocyteAssociated 4 PE (CTLA4PE; clone BNI3; BD), Ki-67PE (clone B56-EMPTY; BD Biosciences), FOXP3FITC/PE (clone PCH101; eBioscience), T-box 21 (TBX21, also known as TBET) PE (clone eBio4B10; eBioscience), GATAbinding protein 3 PE (GATA3PE; clone TWAJ; eBioscience), or RORCPE (clone AFKJS-9; eBioscience) for 30 min at 48C. Thereafter, cells were washed and resuspended in PBS 0.1% fetal bovine serum. A total of 100 000 lymphocytes were collected and analyzed using FACSCanto II (BD Biosciences) and the FACSDiva software (version 5.0.1; BD Biosciences).
Flow Cytometric Gating
The lymphocyte gate in a side scatter/forward scatter plot was adjusted to fit the small fixated and permeabilized cells (Fig. 1A) [20] . Hence, although identifying comparable cell populations, the gating strategies described above resulted in different gates for blood and decidua.
Statistics
Because the majority of the data followed a Gaussian distribution, and blood and decidual tissue was obtained from the same patient, all data were analyzed using Student paired t-test. Because of the many statistical comparisons, P 0.01 was considered significant. All data are presented as mean 6 SD. Statistical analysis was performed using the GraphPad Prism 5 software (GraphPad Software Inc., San Diego, CA).
RESULTS
Nonenzymatic Isolation of T-Helper Cells from First-Trimester Decidua
After isolation of mononuclear cells using Ficoll-Paque plus density gradient centrifugation, 77.5% 6 11.2% of all the cells in decidua expressed the leukocyte marker CD45
þ , compared with 98.2% 6 1.4% in blood (P 0.0001). In the side scatter/ forward scatter lymphocyte gate, fewer cells were CD45 þ in decidua (Fig. 1B ) than in blood (Fig. 1A) , and significantly fewer of the CD45 þ leukocytes in decidua were CD3 þ T cells ( Fig. 1B , P 0.001), in accordance with previous reports [2] . Further, CD4 þ cells were less common within the CD3 þ T-cell compartment in the decidua (Fig. 1B , P 0.001).
The Quantitative Relationship Between Treg, T H 1, T H 2, and T H 17 Cells in Decidua and Blood
CD4
þ T cells expressing high levels of CD25 (CD4 dim CD25 high ) and FOXP3 (FOXP3 high ), indicative of immune-suppressive function, were numerically increased in the decidua compared with blood (Fig 1, C , P 0.01, and D, P 0.001). A majority of the blood CD4 dim CD25 high cells expressed the Treg-cell-associated protein FOXP3, an expression that was even higher in decidua ( Fig. 2B , P 0.01 for FOXP3 þ and P 0.001 for FOXP3 high ). Furthermore, the total proportion of FOXP3-expressing cells in the CD4 þ population was higher in decidua ( Fig. 1D , P 0.01). Interestingly, the intensity of FOXP3 expression was increased on decidual CD4 þ cells. Thus, the decidual CD4 þ and CD4 dim CD25 high populations contained a larger proportion of FOXP3 high cells than in blood (Figs. 1D, P 0.001, and 2B, P 0.001). CD127 low in combination with CD25 has been proposed as a surface marker for identification of FOXP3 þ cells [26, 27] . The proportion of CD4 þ cells coexpressing CD127 low and CD25 high was increased in decidua compared with blood ( Fig. 1E , P 0.01). Treg cells were thus enriched in decidua, regardless of whether they were defined as
The presence of T H 2 cells, defined according to chemokine receptor expression (Fig. 3, A and C) , was similar in blood and decidua, although a tendency toward a reduction of this REGULATORY T CELLS AND T HELPER SUBSETS IN DECIDUA population was observed in decidua ( Fig. 3C , P ¼ 0.06). Further, significantly fewer T H 17 cells were found in decidua than in blood (Fig. 3 , A and D, P 0.001). Blood CCR6
þ T H 1 cells have previously been reported to show a mixed T H 17/T H 1 phenotype, with production of RORC mRNA and IL17 alongside higher levels of TBX21 mRNA and IFNG than CCR6
À T H 1 cells, indicating higher T H 1 activity [29] . The CCR6 þ T H 1 frequency was decreased (Fig. 3 , A and E, P 0.01) and the CCR6
À T H 1-cell frequency increased (Fig. 3 , A and F, P 0.001) within the decidual CD4 þ population compared with blood. Owing to the recent availability of antibodies against human TBX21 (T H 1), GATA3 (T H 2), and RORC (T H 17), we were able to confirm the usage of CCR4, CCR6, and CXCR3 profiles for identifying T H 1, T H 2, and T H 17 cells (Fig. 3, G-I) . Because of the small number of cells recovered from decidual tissue, this was performed using blood from healthy nonpregnant women. The transcription factor dominating the different populations was GATA3 for the T H 2 (CCR6 (Fig. 1C, P 0.001) . In both decidua and blood, few CD4 þ CD25 dim cells expressed FOXP3, whereas they often expressed CD45R0 ( Fig. 2A) , hence pointing toward a nonsuppressive but memory/activated status of CD4 þ CD25 dim cells. This was particularly evident in decidua, where a high proportion of CD4 þ
CD25
dim cells also expressed HLA-DR ( Fig. 2A, P 0.001). Importantly, more CD4 þ CD25 dim cells expressed the immune-suppressive molecule CTLA4 in decidua than in blood ( Fig. 2A, P 0.001) .
þ , and FOXP3 high Cells in Decidua and Blood
In both blood and decidua, the FOXP3 high population showed a more homogenous memory/activated Treg-cell phenotype than the total FOXP3 þ population, with a higher presence of CD45R0 þ , HLA-DR þ , and CTLA4 þ cells (Fig.  2C ). More decidual FOXP3 þ and FOXP3 high cells expressed CD45R0, HLA-DR, and CTLA4 relative blood (Fig. 2C , P 0.001 or P 0.01). This expression pattern was also true for CD4 dim CD25 high cells (Fig. 2B , P 0.001 or P 0.01).
Expression of CCR4 on Treg Cells in Decidua and Blood
Generally, in both decidua and blood, more Treg cells (regardless of whether they were defined as (Table 2 ). In the CD25 þ CD127 low gate, on average, only 64% of the cells were FOXP3 þ and 35% FOXP3 high in the decidua (Table 2 ). Most importantly, we found that the CD127 low phenotype adds no extra enrichment or purity with regard to FOXP3, neither in decidua nor in blood, compared with the CD4 dim CD25 high phenotype (Table  2) .
DISCUSSION
Regulatory T cells and CCR6
À T H 1 cells were enriched, whereas T H 17 and CCR6
þ T H 1 cells were fewer in the decidua than in the circulation in first-trimester pregnancy. Furthermore, the Treg cells found at the fetal-maternal interface had a much more homogenous Treg cell phenotype than circulating Treg cells, with many cells expressing FOXP3, CTLA4, and
dim population (A) and the CD4 dim CD25 high Treg cell population (B) in decidua (filled dots) and matched blood (unfilled dots).
high populations in blood (unfilled dots) and decidua (filled dots). Lines indicate means. **P 0.01, ***P 0.001.
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HLA-DR. The decidual enrichment of Treg cells may be a result of local proliferation of these cells as judged by their more frequent expression of MKI67 (identified by monoclonal antibody Ki-67). Our findings support and extend previous knowledge on how the fetal tissue is tolerated by the maternal immune system. Even though fetal cells can escape to the maternal blood circulation, the main tolerance must take place at the fetal-maternal interface (i.e., involving maternal immune cells in the decidua). Failure to do so may result in pregnancy failure [33] . Hence, healthy pregnancy is a model of successful tolerance, and the application of new knowledge from this model will promote other fields of immunology. T H 1, T H 2, and T H 17 cells, defined by their cytokine production (IFNG, IL4, and IL17, respectively) and Treg cells, defined by FOXP3 expression, have different but partly overlapping chemokine receptor profiles [34] . In blood, T H 1, T H 2, and T H 17 cells could be distinguished based on expression of CCR4, CCR6, and CXCR3, even under inflammatory conditions and in tissues [29] . In the current study, we confirmed that the T H 2, T H 17, CCR6
þ T H 1, and CCR6
À T H 1 populations in blood were dominated by cells expressing the lineage-associated transcription factors [28, 35] 
GATA3 (T H 2), RORC (T H 17), TBX21 (CCR6
À T H 1), and TBX21/RORC (CCR6 þ T H 1), respectively. By applying this chemokine receptor profiling approach, we found that T H 17 and CCR6
þ T H 1 cells were fewer, whereas T H 2 cells and CCR6
À T H 1 cells were unaltered or increased, respectively, in first-trimester decidua compared with blood. Although not confirmed here, CCR6
þ T H 1 cells secreted more IFNG and expressed more TBX21 mRNA, indicative of a higher T H 1 
activity than CCR6
À T H 1 cells [29] . Previous studies have shown decreased local T H 1 activity in first-trimester pregnancy [6] . However, even if increased production of IFNG is associated with human pregnancy loss [36] , transient production of IFNG seems to be consistent with the early phases of pregnancy [37] , ensuring proper placental implantation [36] . Thus, impediment of the CCR6 þ T H 1 cells and promotion of the seemingly less aggressive CCR6
À T H 1 cells may contribute with an appropriate amount of IFNG to ensure healthy pregnancy without fetal rejection. In contrast to previous studies [5] , we did not observe an increased presence of T H 2 cells in first-trimester decidua, possibly because of the different methods used for identifying T H 2 cells. One limitation of the CCR4/CCR6/CXCR3 strategy for identification of T H 1, T H 2, and T H 17 cells is that it does not take into account FOXP3 þ regulatory cells, of which most express CCR4 and CCR6 [34] . However, because FOXP3 þ cells were greatly enriched in decidua, and FOXP3 þ cells show a chemokine receptor profile mostly overlapping with T H 17 and T H 2 cells [34] , it is unlikely that the FOXP3 þ cells were contaminating these populations to any considerable extent, because they were not increased in decidua. Another limitation of using chemokine receptor expression could be downregulation of these receptors in decidual tissue. However, speaking against this, CCR6 expression was useful for identifying T H 17 cells in synovial fluid from arthritis patients [29] .
Increased levels of the CCR6 ligand CCL20 in amniotic fluid was associated with prematurity [38] . Hence, in accordance with our results, it is unlikely that many CCR6 þ cells (T H 1 CCR6 þ and T H 17 cells) are recruited to the decidua in early, seemingly healthy pregnancies. Although Treg cells have been shown to express CCR6 [39] , these cells may be recruited to the decidua by other pathways, such as via CCL17-CCR4 interactions. The CXCR3 ligands CXCLs 9-11 are all produced at the healthy fetal-maternal interface, acting on CXCR3 expressed on trophoblasts to induce migration and implantation [40] . This supports the high incidence of CCR6 À T H 1 cells in decidua.
In mice, Treg cells have been found to be in a reciprocal relationship with other differentiated T-helper cell subsets, such as T H 2 [41] and T H 17 [14] . Further, it was recently shown that human Treg cells can develop into T H 17 cells [12] , indeed substantiating the tight relationship between these T-helper subsets. The balance between Treg cells and their target/ reciprocal cell types most likely reflects immune status better than investigating Treg-cell frequency alone. In the current study, we found that the presence of Treg cells and T H 17 cells in the decidua were inversely related to each other, Treg cells being enriched and T H 17 cells being barely detectable in decidua. Although controversial, both human Treg [42] and T H 17 cells [43] [44] [45] seem to be, directly or indirectly [46] , supported by TGFB, with T H 17 development demanding additional factors such as IL1B, IL23, IL21, and IL6 [43] [44] [45] . Further, in mice, T H 17 development is possibly favored by lower TGFB concentrations than those generating Treg cells [14, 47] . Our data on Treg-cell augmentation in decidua indicate that the effects of TGFB are dominating, hence promoting Treg cells in decidua, which fits well with the general view of this cytokine as a pregnancy facilitator [48] . In support of this notion, seminal fluid, which has a high TGFB content, was recently found to promote expansion of the Tregcell compartment [49] .
The circulating levels of Treg cells during the first trimester of normal pregnancy were similar to the levels we previously found in normal second-trimester pregnancy [20] , where pregnant women had fewer circulating Treg cells than nonpregnant women. Hence, it is tempting to speculate that circulating Treg cells migrate to the fetal-maternal interface already during first-trimester pregnancy, causing a drop in circulating Treg-cell numbers and contributing to a local enrichment of Treg cells in decidua, an idea also supported by others [22] . However, migratory mechanisms have not been examined, and an alternative or complementary explanation could be local expansion of Treg cells. The MKI67 protein has traditionally been used in tumor research because it is expressed in all active phases of the cell cycle, maximally in mitosis but not in G 0 phase, making it a crude but robust marker of proliferation [50] . We found that Treg cells at the fetal-maternal interface proliferated more than circulating Treg cells, in fact proliferating even more than activated nonregulatory CD4
þ CD25 dim cells. In parallel, fewer Treg cells at the fetal-maternal interface than in the circulation expressed CCR4, possibly because of receptor downregulation. Speaking against this, CCL17, being highly expressed at the fetalmaternal interface [32] , induced strikingly little CCR4 downregulation compared with CCL22 [51] . Although the [24, 25] that upon in vitro blocking reduce the suppressive activity of Treg cells [54, 55] . HLA-DR þ Treg cells, as opposed to HLA-DR À Treg cells, may suppress in a rapid, FOXP3-dependent but cytokine-independent manner [25] . We found that more decidual than circulating Treg cells expressed these molecules, including FOXP3, indicating a higher immunesuppressive activity [56] . Even if FOXP3 can be transiently induced in nonregulatory T cells by T-cell receptor stimulation in vitro, sustained high expression is associated with regulatory function [57] , still making it a useful marker for ex vivoisolated Treg cells. However, its intracellular expression greatly limits the usefulness as a marker for sorting viable Treg cells to be examined in functional assays. CD127 has been proposed a surrogate surface marker for FOXP3 because these two proteins are inversely correlated, FOXP3
þ cells being CD127 low [26, 27] . Liu et al. [26] suggested that a highly pure FOXP3 population could be sorted on the basis of a CD4 þ CD25 þ CD127 low phenotype. However, we argue that defining Treg cells as CD4 þ CD25 high CD127 low rather than CD4 þ CD25 þ CD127 low results in a strikingly more FOXP3-pure population. Yet, adding the CD127 low marker does not enhance the FOXP3 purity compared with using just CD25 high . This finding has implications when sorting viable Treg cells from both blood and decidua.
The variability in the parameters investigated was not higher than previously observed [22] . Importantly, although the variability between individual women was occasionally large, the differences observed between blood and decidua were generally consistent, supporting a biological significance. Another concern is that all patients were given oral prostaglandin E1 (PGE1) agonist misoprostol (Cytotec) 2-6 h prior to the surgical abortion. PGE1 reduces the secretion of IL2 and IFNG but not IL4 or IL10 from PBMCs [58] . Although PGE2 may enhance both Treg and T H 17 cells [59, 60] , the effects of PGE1 on these subsets have, to our knowledge, not been investigated. In total, misoprostol could possibly have affected the cell subsets investigated. However, because misoprostol was orally administered, both peripheral and local immune cells would be influenced, thereby limiting the impact of this treatment on the results.
In conclusion, using several markers of Treg cells, we show that these cells are enriched in decidua compared with blood. Decidual Treg cells, possessing a more homogenous Treg-cell phenotype, seem to proliferate more and also constitute a large proportion of the cells that can be recruited to the decidua via the CCR4 ligands. Whereas Treg cells and CCR6
À T H 1 cells were enriched, aggressive CCR6
þ T H 1 and T H 17 cells were much less frequent in decidua compared with blood. Our results support and extend the view that moderate T H 1 activity is a part of early pregnancy, consistent with a mild inflammatory environment controlled by Treg cells.
